
Sign up to save your podcasts
Or


Moderator: J. Quentin Clemens, MD, FACS
Risk Profile of Anticholinergic Agents vs Beta-3 Agonists
Panelist: Anne M. Suskind, MD, MS, FACS, FPMRS
Efficacy of Anticholinergic Agents vs Beta-3 Agonists
Panelist: Blayne Welk, MD
What About Neurogenic Bladder?
Panelist: Christopher S. Elliott, MD, PhD
By SUFU podcast5
33 ratings
Moderator: J. Quentin Clemens, MD, FACS
Risk Profile of Anticholinergic Agents vs Beta-3 Agonists
Panelist: Anne M. Suskind, MD, MS, FACS, FPMRS
Efficacy of Anticholinergic Agents vs Beta-3 Agonists
Panelist: Blayne Welk, MD
What About Neurogenic Bladder?
Panelist: Christopher S. Elliott, MD, PhD